Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.64
7.61
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Shandong Weigao Group Medical Polymer Co Ltd
Current Portion of Long-Term Debt
Shandong Weigao Group Medical Polymer Co Ltd
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Current Portion of Long-Term Debt
ÂĄ673.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
||
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
Current Portion of Long-Term Debt
ÂĄ92.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
73%
|
CAGR 10-Years
N/A
|
||
Autobio Diagnostics Co Ltd
SSE:603658
|
Current Portion of Long-Term Debt
ÂĄ300.3m
|
CAGR 3-Years
213%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Winner Medical Co Ltd
SZSE:300888
|
Current Portion of Long-Term Debt
ÂĄ222.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Current Portion of Long-Term Debt
ÂĄ1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Intco Medical Technology Co Ltd
SZSE:300677
|
Current Portion of Long-Term Debt
ÂĄ11.2m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Shandong Weigao Group Medical Polymer Co Ltd
Glance View
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Weihai, Shandong. The company went IPO on 2004-02-27. The firm sells products under brand names of Jierui and Wego Ortho. The firm operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The firm is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
See Also
What is Shandong Weigao Group Medical Polymer Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
673.9m
CNY
Based on the financial report for Jun 30, 2024, Shandong Weigao Group Medical Polymer Co Ltd's Current Portion of Long-Term Debt amounts to 673.9m CNY.
What is Shandong Weigao Group Medical Polymer Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-4%
Over the last year, the Current Portion of Long-Term Debt growth was -26%. The average annual Current Portion of Long-Term Debt growth rates for Shandong Weigao Group Medical Polymer Co Ltd have been -9% over the past three years , -4% over the past five years .